Expression of transforming growth factor-β1 and tumour necrosis factor-α in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin

Respirology

Volumn 4, Issue 4, 1999, Pages 359-363

  Maeda, Akihiro ^a   Ishioka, Shinichi ^a   Taooka, Yasuyuki ^a   Hiyama, Keiko ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bleomycin; Bronchoalveolar lavage; Mouse; Pulmonary fibrosis; Reverse transcription polymerase chain reaction; Transforming growth factor ; Tumour necrosis factor

Indexed keywords

BLEOMYCIN; SIVELESTAT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAPERITONEAL; MICE; PROBABILITY; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033377801     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.1999.00205.x     Document Type: Article

References (14)

1. Kelley J. Cytokines of the lung. Am. Rev. Respir. Dis. 1990; 141: 765-88.
2. Adamson IYR, Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 1974; 77: 185-98.
3. Aso Y, Yoneda K, Kikkawa Y. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab. Invest. 1976; 35: 558-68.
4. Snider GL, Hayes JA, Korthy AL. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am. Rev. Respir. Dis. 1978; 117: 1099-108.
5. Maeda A, Hiyama K, Yamakido H, Ishioka S, Yamakido M. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 1996; 109: 780-6.
6. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumour necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 1989; 170: 655-63.
7. Kelley J. Transforming growth factor-β. In: Kelley J, ed. Cytokines of the Lung. New York: Marcel Dekker, 1993; 101-37.
8. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 1989; 170: 727-37.
9. Raghow R, Irish P, Kang AH. Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycininduced pulmonary fibrosis. J. Clin. Invest. 1989; 84: 1836-42.
10. Westergren-Thorsson G, Hernnäs J, Särnstrand B, Oldberg A, Heinegård D, Malmström A. Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 1993; 92: 632-7.
11. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun. 1991; 177: 814-20.
12. Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M. Effects of neutrophil elastase inhibitor on bleomycininduced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 1997; 156: 260-5.
13. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW. Regulation of rat pulmonary artery endothelial cell transforming growth factor-β production by ILIβ and tumour necrosis factor-α. J. Immunol. 1992; 149: 103-6.
14. Santana A, Saxena B, Noble NA, Gold LI, Marshall BC. Increased expression of transforming growth factor β isoforms (β1, β2, β3) in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 1995; 13: 34-44.